Showing results (291-300 of 301) with videos related to

Sort By:
Pageof 31
Pediatrics|July 17, 2016
Safety Profile of the 9-Valent HPV Vaccine: A Combined Analysis of 7 Phase III Clinical TrialsEdson D Moreira, Stan L Block, Daron Ferris, et al.
The American Journal of Tropical Medicine and Hygiene|December 7, 2011
Characterization of novel Leishmania infantum recombinant proteins encoded by genes from five families with distinct capacities for serodiagnosis of canine and human visceral leishmaniasisGeraldo G S Oliveira, Franklin B Magalhães, Márcia C A Teixeira, et al.
Physiological Reports|October 2, 2025
Multiomics investigation of the female hypertensive human heartZachary J Milstone, Jesse D Moreira-Bouchard, Karan K Smith, et al.
Papillomavirus Research (Amsterdam, Netherlands)|December 23, 2017
Efficacy, immunogenicity, and safety of a 9-valent human papillomavirus vaccine in Latin American girls, boys, and young womenÁngela María Ruiz-Sternberg, Edson D Moreira, Jaime A Restrepo, et al.
American Journal of Physiology. Heart and Circulatory Physiology|November 24, 2023
Guidelines on the use of sex and gender in cardiovascular researchCharlotte W Usselman, Merry L Lindsey, Austin T Robinson, et al.
Papillomavirus Research (Amsterdam, Netherlands)|July 20, 2017
Impact of baseline covariates on the immunogenicity of the 9-valent HPV vaccine - A combined analysis of five phase III clinical trialsLone K Petersen, Jaime Restrepo, Edson D Moreira, et al.
Nucleic Acids Research|May 25, 2026
Mitochondrial genetic variation across tissues of the human bodyNathaniel Fisher, Liying Xue, Karan K Smith, et al.
The New England Journal of Medicine|February 19, 2015
A 9-valent HPV vaccine against infection and intraepithelial neoplasia in womenElmar A Joura, Anna R Giuliano, Ole-Erik Iversen, et al.
The New England Journal of Medicine|December 10, 2020
Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineFernando P Polack, Stephen J Thomas, Nicholas Kitchin, et al.
The New England Journal of Medicine|September 15, 2021
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 MonthsStephen J Thomas, Edson D Moreira, Nicholas Kitchin, et al.
Pageof 31